These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 33814448)
41. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice. Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195 [TBL] [Abstract][Full Text] [Related]
42. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600 [TBL] [Abstract][Full Text] [Related]
43. AMPK Ameliorates Tau Acetylation and Memory Impairment Through Sirt1. Wang L; Shi FX; Li N; Cao Y; Lei Y; Wang JZ; Tian Q; Zhou XW Mol Neurobiol; 2020 Dec; 57(12):5011-5025. PubMed ID: 32820462 [TBL] [Abstract][Full Text] [Related]
44. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice. Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846 [TBL] [Abstract][Full Text] [Related]
45. Central acylated ghrelin improves memory function and hippocampal AMPK activation and partly reverses the impairment of energy and glucose metabolism in rats infused with β-amyloid. Kang S; Moon NR; Kim DS; Kim SH; Park S Peptides; 2015 Sep; 71():84-93. PubMed ID: 26188171 [TBL] [Abstract][Full Text] [Related]
46. PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease. Dumont M; Stack C; Elipenahli C; Jainuddin S; Launay N; Gerges M; Starkova N; Starkov AA; Calingasan NY; Tampellini D; Pujol A; Beal MF FASEB J; 2014 Apr; 28(4):1745-55. PubMed ID: 24398293 [TBL] [Abstract][Full Text] [Related]
47. Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears Amyloid-β and Tau in a Mouse Model of Alzheimer's Disease. Lee S; Choi BR; Kim J; LaFerla FM; Park JHY; Han JS; Lee KW; Kim J Mol Nutr Food Res; 2018 Jun; 62(12):e1800240. PubMed ID: 29714053 [TBL] [Abstract][Full Text] [Related]
48. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ. Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265 [TBL] [Abstract][Full Text] [Related]
49. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
50. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer's disease. Chavoshinezhad S; Mohseni Kouchesfahani H; Salehi MS; Pandamooz S; Ahmadiani A; Dargahi L Brain Res Bull; 2019 Aug; 150():297-306. PubMed ID: 31233762 [TBL] [Abstract][Full Text] [Related]
51. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice. Tapia-Rojas C; Inestrosa NC J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990 [TBL] [Abstract][Full Text] [Related]
52. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway. Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922 [TBL] [Abstract][Full Text] [Related]
53. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments. Mahaman YAR; Huang F; Wu M; Wang Y; Wei Z; Bao J; Salissou MTM; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Chen D; Wang X J Alzheimers Dis; 2018; 63(3):1141-1159. PubMed ID: 29710724 [TBL] [Abstract][Full Text] [Related]
54. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease. Wilcock DM; Gharkholonarehe N; Van Nostrand WE; Davis J; Vitek MP; Colton CA J Neurosci; 2009 Jun; 29(25):7957-65. PubMed ID: 19553436 [TBL] [Abstract][Full Text] [Related]
55. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026 [TBL] [Abstract][Full Text] [Related]
56. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms. Du Y; Qu J; Zhang W; Bai M; Zhou Q; Zhang Z; Li Z; Miao J Neuropharmacology; 2016 Sep; 108():1-13. PubMed ID: 27067919 [TBL] [Abstract][Full Text] [Related]
57. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
58. Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor. Shin KY; Noh SJ; Park CH; Jeong YH; Chang KA; Yoo J; Kim HJ; Ha S; Kim HS; Park HJ; Lee JH; Moon C; Suh YH CNS Neurol Disord Drug Targets; 2016; 15(8):935-944. PubMed ID: 27577574 [TBL] [Abstract][Full Text] [Related]
59. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease. Petrov D; Luque M; Pedrós I; Ettcheto M; Abad S; Pallàs M; Verdaguer E; Auladell C; Folch J; Camins A Mol Neurobiol; 2016 Nov; 53(9):6183-6193. PubMed ID: 26558630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]